Exosomes Market (By Product: Kits & Reagents, Services; By Application: Cancer, CVD; By Workflow: Isolation Methods, Downstream Analysis; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global exosomes market was valued at USD 112.3 million in 2022 and it is predicted to surpass around USD 1,915.85 million by 2032 with a CAGR of 32.8% from 2023 to 2032.

Exosomes Market Size 2023 to 2032

Key Pointers

  • The kits and reagents product segment captured the highest share of 44.86% in 2022.
  • The services segment is anticipated to register a rapid growth rate during the forecast years. 
  • The downstream analysis segment held the largest share of 58.48% in 2022.
  • The isolation methods segment is projected to grow at a lucrative CAGR over the forecast period.
  • The cancer segment held the largest market share of 31.9% in 2022.
  • The infectious diseases segment is expected to expand at a rapid CAGR during the forecast period. 
  • The pharmaceutical & biotechnology companies segment captured the highest revenue share of 49.42% in 2022.
  • The academic & research institutes segment is anticipated to grow at a significant CAGR over the forecast period.
  • North America accounted for the highest share of 55.5% in 2022 and is projected to grow at the fastest rate over the forecast period.
  • The Europe region is expected to grow at a rapid CAGR during the forecast period.

Report Scope of the Exosomes Market

Report Coverage Details
Market Size in 2022 USD 112.3 million
Revenue Forecast by 2032 USD 1,915.85 million
Growth rate from 2023 to 2032 CAGR of 32.8%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Danaher Corporation; Hologic Inc.; Fujifilm Holdings Corporation; Lonza; Miltenyi Biotec; Bio-Techne Corporation; QIAGEN; Thermo Fisher Scientific, Inc.; Abcam plc; RoosterBio, Inc.

 

Exosomes are also known as Extracellular Vesicles (EVs) and are encased within a single outer membrane. They are secreted by all cell types and have been found in saliva, urine, plasma, semen, breast milk, Cerebral Spinal Fluid (CSF), amniotic fluid, bronchial fluid, bile, lymph, serum, gastric acid, synovial fluid, and tears. These vesicles carry proteins and genetic information throughout the body and create paths for communication between cells.

The key factors driving the industry include technological advancements in exosome isolation and analytical procedures, advanced applications of exosomes, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.

Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years. For instance, in August 2022, researchers at the North Carolina State University developed an inhalable COVID-19 vaccine based on exosomes. Exosomes can also be used to determine the onset or progress of multiple diseases, including infectious diseases, neurodegenerative diseases, cancer, and Cardiovascular Diseases (CVDs), among others.

Moreover, the advantages of exosomes in drug delivery, such as biological barrier permeability, low immunogenicity and toxicity, and stability in circulation are increasing the therapeutics applications in this domain. Thus, the potential applications of extracellular vesicles in diagnostics, therapeutics, and vaccine development are projected to drive the industry over the forecast period. The growing prevalence of cancer is leading to a high demand for effective novel therapeutic options for the diagnosis and treatment of the disease. For instance, according to the World Health Organization (WHO), in 2020, there were about 10 million cancer deaths, making it one of the foremost causes of death worldwide.

Moreover, in the U.S., according to the American Cancer Society, an estimated 1,918,030 new cancer cases and 609,360 cancer deaths were recorded by the end of 2022. Furthermore, technological advancements in exosome isolation and analytical procedures are anticipated to boost industry growth during the forecast years. For instance, in November 2022, Cell Guidance Systems introduced its Instant Exosomes and LipoQ assay products. The Instant Exosomes are freeze-dried exosomes and LipoQ is a lipid quantification assay for research applications. Such, developments are expected to boost the adoption of exosomes for research purposes and drive industry growth.

Exosomes Market Segmentations:

By Product

  • Kits & Reagents
  • Instruments
  • Services

By Workflow

  • Isolation Methods
    • Ultracentrifugation
    • Immunocapture on beads
    • Precipitation
    • Filtration
    • Others
  • Downstream Analysis
    • Cell surface marker analysis using flow cytometry
    • Protein analysis using blotting & ELISA
    • RNA analysis with NGS & PCR
    • Proteomic analysis using mass spectroscopy
    • Others

By Application

  • Cancer
  • Neurodegenerative diseases
  • Cardiovascular diseases
  • Infectious diseases
  • Others

By End-use

  • Pharmaceutical & biotechnology companies
  • Hospitals & diagnostics centers
  • Academic & research institutes

Frequently Asked Questions

The global exosomes market size was reached at USD 112.3 million in 2022 and it is projected to hit around USD 1,915.85 million by 2032.

The global exosomes market is growing at a compound annual growth rate (CAGR) of 32.8% from 2023 to 2032.

The North America region has accounted for the largest exosomes market share in 2022.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Exosomes Market 

5.1. COVID-19 Landscape: Exosomes Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Exosomes Market, By Product

8.1. Exosomes Market, by Product, 2023-2032

8.1.1. Kits & Reagents

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Instruments

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Exosomes Market, By Workflow

9.1. Exosomes Market, by Workflow, 2023-2032

9.1.1. Isolation Methods

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Downstream Analysis

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Exosomes Market, By Application 

10.1. Exosomes Market, by Application, 2023-2032

10.1.1. Cancer

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Neurodegenerative diseases

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Cardiovascular diseases

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Infectious diseases

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Exosomes Market, By End-use 

11.1. Exosomes Market, by End-use, 2023-2032

11.1.1. Pharmaceutical & biotechnology companies

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Hospitals & diagnostics centers

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Academic & research institutes

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Exosomes Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.1.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Forecast, by End-use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.2.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.3.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.4.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-use (2020-2032)

Chapter 13. Company Profiles

13.1. Danaher Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Hologic Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Fujifilm Holdings Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Lonza

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Miltenyi Biotec

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bio-Techne Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. QIAGEN

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Thermo Fisher Scientific, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Abcam plc

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. RoosterBio, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert